These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 1487241)
21. Mutations of the tyrosinase gene in Indo-Pakistani patients with type I (tyrosinase-deficient) oculocutaneous albinism (OCA). Tripathi RK; Bundey S; Musarella MA; Droetto S; Strunk KM; Holmes SA; Spritz RA Am J Hum Genet; 1993 Dec; 53(6):1173-9. PubMed ID: 7902671 [TBL] [Abstract][Full Text] [Related]
22. A frequent tyrosinase gene mutation associated with type I-A (tyrosinase-negative) oculocutaneous albinism in Puerto Rico. Oetting WS; Witkop CJ; Brown SA; Colomer R; Fryer JP; Bloom KE; King RA Am J Hum Genet; 1993 Jan; 52(1):17-23. PubMed ID: 8434585 [TBL] [Abstract][Full Text] [Related]
23. Mutations of the tyrosinase gene in three Korean patients with type I oculocutaneous albinism. Park KC; Park SK; Lee YS; Youn SW; Park BS; Kim KH; Lee ST Jpn J Hum Genet; 1996 Sep; 41(3):299-305. PubMed ID: 8996965 [TBL] [Abstract][Full Text] [Related]
24. Detection of 53 novel DNA variations within the tyrosinase gene and accumulation of mutations in 17 patients with albinism. Opitz S; Käsmann-Kellner B; Kaufmann M; Schwinger E; Zühlke C Hum Mutat; 2004 Jun; 23(6):630-1. PubMed ID: 15146472 [TBL] [Abstract][Full Text] [Related]
25. A nonsense mutation in the tyrosinase gene of Afghan patients with tyrosinase negative (type IA) oculocutaneous albinism. Giebel LB; Musarella MA; Spritz RA J Med Genet; 1991 Jul; 28(7):464-7. PubMed ID: 1832718 [TBL] [Abstract][Full Text] [Related]
26. Diverse mutations of the P gene among African-Americans with type II (tyrosinase-positive) oculocutaneous albinism (OCA2). Lee ST; Nicholls RD; Schnur RE; Guida LC; Lu-Kuo J; Spinner NB; Zackai EH; Spritz RA Hum Mol Genet; 1994 Nov; 3(11):2047-51. PubMed ID: 7874125 [TBL] [Abstract][Full Text] [Related]
27. Temperature-sensitive tyrosinase associated with peripheral pigmentation in oculocutaneous albinism. King RA; Townsend D; Oetting W; Summers CG; Olds DP; White JG; Spritz RA J Clin Invest; 1991 Mar; 87(3):1046-53. PubMed ID: 1900307 [TBL] [Abstract][Full Text] [Related]
28. Sequence analysis of tyrosinase gene in ocular and oculocutaneous albinism patients: introducing three novel mutations. Khordadpoor-Deilamani F; Akbari MT; Karimipoor M; Javadi G Mol Vis; 2015; 21():730-5. PubMed ID: 26167114 [TBL] [Abstract][Full Text] [Related]
29. The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase. Toyofuku K; Valencia JC; Kushimoto T; Costin GE; Virador VM; Vieira WD; Ferrans VJ; Hearing VJ Pigment Cell Res; 2002 Jun; 15(3):217-24. PubMed ID: 12028586 [TBL] [Abstract][Full Text] [Related]
30. Cloning and sequence analysis of the tyrosinase gene from a patient with tyrosinase-positive oculocutaneous albinism. Matsunaga J; Takeda A; Tomita Y; Hara M; Shibahara S; Tagami H J Dermatol Sci; 1992 May; 3(3):181-5. PubMed ID: 1498098 [TBL] [Abstract][Full Text] [Related]
31. R278TER and P431L mutations of the tyrosinase gene exist in Japanese patients with tyrosinase-negative oculocutaneous albinism. Matsunaga J; Dakeishi M; Shimizu H; Tomita Y J Dermatol Sci; 1996 Nov; 13(2):134-9. PubMed ID: 8953413 [TBL] [Abstract][Full Text] [Related]
32. Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype. King RA; Pietsch J; Fryer JP; Savage S; Brott MJ; Russell-Eggitt I; Summers CG; Oetting WS Hum Genet; 2003 Nov; 113(6):502-13. PubMed ID: 13680365 [TBL] [Abstract][Full Text] [Related]
33. Insertion/deletion mutations of type I oculocutaneous albinism in chinese patients from Taiwan. Tsai CH; Tsai FJ; Wu JY; Lin SP; Chang JG; Yang CF; Lee CC Hum Mutat; 1999 Dec; 14(6):542. PubMed ID: 10571953 [TBL] [Abstract][Full Text] [Related]
34. Tyrosinase gene mutations associated with type IB ("yellow") oculocutaneous albinism. Giebel LB; Tripathi RK; Strunk KM; Hanifin JM; Jackson CE; King RA; Spritz RA Am J Hum Genet; 1991 Jun; 48(6):1159-67. PubMed ID: 1903591 [TBL] [Abstract][Full Text] [Related]
35. A Tyrosinase missense mutation causes albinism in the Wistar rat. Blaszczyk WM; Arning L; Hoffmann KP; Epplen JT Pigment Cell Res; 2005 Apr; 18(2):144-5. PubMed ID: 15760344 [TBL] [Abstract][Full Text] [Related]
36. The Molecular Basis of Chemical Chaperone Therapy for Oculocutaneous Albinism Type 1A. Teramae A; Kobayashi Y; Kunimoto H; Nakajima K; Suzuki T; Tsuruta D; Fukai K J Invest Dermatol; 2019 May; 139(5):1143-1149. PubMed ID: 30447237 [TBL] [Abstract][Full Text] [Related]
37. Molecular basis of tyrosinase-negative oculocutaneous albinism. A single base mutation in the tyrosinase gene causing arginine to glutamine substitution at position 59. Takeda A; Tomita Y; Matsunaga J; Tagami H; Shibahara S J Biol Chem; 1990 Oct; 265(29):17792-7. PubMed ID: 2120217 [TBL] [Abstract][Full Text] [Related]